Compare AROC & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AROC | LIVN |
|---|---|---|
| Founded | 1990 | 1987 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 4.3B |
| IPO Year | 2007 | 2015 |
| Metric | AROC | LIVN |
|---|---|---|
| Price | $31.55 | $78.50 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 11 |
| Target Price | $42.38 | ★ $90.55 |
| AVG Volume (30 Days) | ★ 1.5M | 517.2K |
| Earning Date | 11-02-2026 | 11-04-2026 |
| Dividend Yield | ★ 2.87% | N/A |
| EPS Growth | ★ 74.29 | N/A |
| EPS | 0.79 | ★ 2.33 |
| Revenue | ★ $1,489,818,000.00 | N/A |
| Revenue This Year | $1.99 | $9.65 |
| Revenue Next Year | $7.77 | $7.10 |
| P/E Ratio | $40.65 | ★ $35.01 |
| Revenue Growth | ★ 28.70 | N/A |
| 52 Week Low | $22.88 | $48.82 |
| 52 Week High | $42.23 | $85.76 |
| Indicator | AROC | LIVN |
|---|---|---|
| Relative Strength Index (RSI) | 56.15 | 50.35 |
| Support Level | $30.00 | $74.69 |
| Resistance Level | $34.43 | $82.39 |
| Average True Range (ATR) | 1.03 | 2.20 |
| MACD | 0.35 | 0.26 |
| Stochastic Oscillator | 79.33 | 48.00 |
Archrock Inc is an energy infrastructure company focused on midstream natural gas compression. It is a provider of natural gas compression services, based on total compression fleet horsepower, to customers across the United States and a supplier of aftermarket services to customers that own compression equipment. The company operates through two segments: contract operations and aftermarket services. The contract operations segment includes designing, sourcing, owning, installing, operating, servicing, repairing, and maintaining its owned fleet of natural gas compression equipment, and generates the maximum revenue. The aftermarket services segment provides operations, maintenance, overhaul, and reconfiguration services, and sales of parts and components.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives approximately half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.